Structure Therapeutics Inc. (GPCR): Dana dhuwit perusahaan

Simbol resmi perusahaan Structure Therapeutics (GPCR)

Structure Therapeutics develops oral GLP-1 drugs by utilizing outsourcing for testing and production, which reduces costs and paves the way for an acquisition by Big Pharma. The size of the cash position confirms financial stability, where the 1.24 mark indicates the current liquidity level. The stability of scientific research is guaranteed by the diversification of chemical component suppliers and research centers.

Structure Pharma - Gunggung dana dhuwit perusahaan GPCR (periode 28.04.2023 - 21.11.2026)

Rincian analitis perusahaan Structure Therapeutics

- nilai saham lan prakiraan konsensus rega:
Analisis fundamental perusahaan:Structure Pharma GPCR
Sampel barang structuretx.com

For the biotechnology sector of Structure Therapeutics (GPCR), where developing diabetes medications requires colossal upfront costs, access to liquidity is critical to ensure scientific scalability. The cash balance trend reflects the current volume of funds, allowing investors to assess the issuer's solvency and its ability to finance research and development without risking business degradation or excessive debt load.

Pesaing wigati

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Agios Pharmaceuticals - Dhuwit awis perusahaan|MDXG: Dhuwit awis lan setara dhuwit awis perusahaan|RZLT: Dhuwit awis perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis lan setara dhuwit awis perusahaan|MBX: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Altimmune, Inc. (ALT)|Dhuwit awis perusahaan AARD|Dana dhuwit perusahaan SGMT|Volume dana dhuwit perusahaan BIOA|Aset likuid perusahaan Biomea Fusion|Dana dhuwit perusahaan Quince Therapeutics QNCX|Volume dana dhuwit perusahaan Fractyl Health, Inc GUTS|VTVT: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Agape ATP|PLUR (Pluri) - Dhuwit awis perusahaan|SYBX - Aset likuid perusahaan|Dana dhuwit perusahaan Lipocine Corp|Volume dana dhuwit perusahaan matinasbiopharma.com|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)